Cervical cancer screening
Lithuania has one of the highest rates of cervical cancer incidents and mortality in Europe. Early-stage cervical cancer generally produces no symptoms and the changes in the cells of the cervix develop over a few years.
In Lithuania, 40% of cases are diagnosed in the advanced stages. Treatment of cervical cancer in the advanced stages is difficult, and there is not much hope of recovery.
Regular cervical cancer screening tests help to detect early changes in the cells of the cervix, and to start treatment to prevent those changes developing into cancer.
For 100% protection from cervical cancer we recommend that these two tests are performed together – human papillomavirus (HPV) and cervical cytology (PAP).
These simple and completely painless tests will protect you and your family from physical and mental suffering that could be caused by a possible oncological condition.
Regular price Regular For clients who are not covered by compulsory health insurance
Cytological examination of cervical smears (PAP smears)
Cytological examination of cervical smears (PAP smears) in liquid-based
HPV 16 and 18 genotypes estimation, screening of high risk genotypes (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68)
HPV high risk genotypes (16,18,26,31,33,35,39,45,51,52,53,56,58,59,66,68,69,73,82)
What factors affect the price?
The prices indicated below apply to citizens of the Republic of Lithuania and the European Union.
If you are coming from another country please check the price by telephoning or sending an email.
When are the examinations are carried out:
Why it is worth
To be examined at our Centre?
- The main test results are available within 1–2 hours.
- We perform high quality tests which has been confirmed by the ISO 15189 certification of our laboratory.
- The results of the tests performed in our laboratory are explained by our staff, a service that is provided by only a few laboratories in the country.
- There is no risk of damage or mix-up of test samples during transportation.
Good to know
- Vaginal discharge that is unusual in consistency, amount or smell;
- Abnormal bleeding after sex, between periods or after menopause;
- Pelvic pain;
- Most commonly – absence of symptoms.
Cervical cancer symptoms in advanced stages 3–4:
- Pain in the pelvis and in the legs;
- Oedemas in the legs (fluid build-up);
- Blood in urine or faeces;
- Pain in the lower back.
Sexual history is the main risk factor when it comes to cervical cancer:
- Becoming sexually active at a young age (younger than 20 years old);
- Having many sexual partners;
- Multiple childbirths;
- Sexually transmitted infections.
- Poor nutrition, vitamin deficiency;
- Weakened immune system.
HPV and PAP are two different tests that can be performed using the same cervical sample. The tests can be performed on the same day when the patient has a consultation with a gynaecologist. The appointments must be booked in advance.
- The results of the most popular tests are usually ready in 2-7 working days.
They can be collected at the reception or we can email them to you upon request.
- If you wish to have your test results explained to you, please call the laboratory on (8 5) 247 64 17.
FAQ (frequently asked questions)
Cervical cancer mainly affects women aged between 35 and 55. The disease usually develops slowly over time, and it may take 10-20 years for the cancer to develop. HPV can cause abnormal changes to cervical epithelial cells. At the beginning, the changes make the cells abnormal but they are still not cancerous. Sometimes the cell changes go away on their own but at times they can develop further. Over a period of several years, the cervical cells may undergo profound changes and, if left untreated, may develop into cervical cancer. Young women owe it to themselves to attend regular appointments with their doctor and have the necessary tests performed, or their risk for cervical cancer may increase. Early diagnosis of pre-cancerous conditions allows for successful treatment.
Practicing safe sex, vaccinations and regular screening tests help to avoid getting cervical cancer.
Studies show that immunising 9-12-year-old girls with the HPV vaccine before they become sexually active may reduce the risk of developing cervical cancer by up to 93%. The vaccination provides immunity against the most common types of human papillomavirus.
Sexually active persons may reduce the risk of contracting or giving HPV to others by using a condom during sexual intercourse.
It is important to understand that immunisation is not a substitute for the cervical cancer preventative measure programme. The vaccine protects against HPV types causing over 70% of cervical cancer cases. The vaccine is effective for approximately 20 years.
Following the necessary tests and the diagnosis of cervical cancer, the treatment options are as follows: surgical treatment, radiation therapy and chemotherapy. Radiotherapy is used to destroy the tumour and chemotherapy, which increases the sensitivity of the cells, is then used to make the treatment more effective. The treatment is complex and takes a long time. Even if the cancer has only spread locally with no presence of metastases in other organs, only about 50-60% of women survive for five years. When cancer is diagnosed at stage 1, over 90% of women survive for five years.